Teleconference explains ways to reduce Medicare costs
Date: December 12th, 2012
The most effective way to slow Medicare spending is to reduce the cases of preventable chronic conditions and incorporate evidence-based care coordination into the traditional Medicare program.
Cynthia Bens Featured for Patient Advocacy Work
Author: Roxanne Yaghoubi, Coalition for Imaging and Bioengineering Research
Date: January 5th, 2012
The Coalition for Imaging & Bioengineering Research (CIBR) ran a story in their Patient Advocate Group (PAG) Spotlight newsletter, titled "Patient Advocate Leader Cynthia Bens Attends RSNA 2011 as Guest of the Coalition for Inaging & Bioengineering Research (CIBR)."
AFib Multiple Chronic Conditions Letter
Author: AFib Optimal Treatment Task Force
Letter from the Afib Optimal Treatment Task Force commenting on the efforts of the Senate Finance Committee's working group on multiple chronic conditions (MCC) policy options white paper.
Assessing Stroke and Bleeding Risk in Atrial Fibrillation--Consensus Statement Executive Summary
This executive summary shares the critical conclusions from the expert consensus statement that makes important recommendations on the use of stroke and bleeding risk tools, the decision to anticoagulate, the incorporation of patient preferences, and more. Read the full consensus here.
The experts include Mark J. Alberts, MD; Mary Amantangelo, MS, ACNP-BC, CCRN; Kenneth A. Bauer, MD; Lynne T. Braun, PhD, CNP, FAHA; Henry I. Bussey, PharmD; A. John Camm, MD, QHP, FRCP, FACC, FESC, FMedSci, FHRS, CStJ; David Garcia, MD; Samuel Z. Goldhaber, MD; Jonathan L. Halperin, MD; Mellanie True Hills; Alan K. Jacobson, MD; Gregory Y.H. Lip, MD, FRCP, FESC, FACC; Edith A. Nutescu, PharmD, FCCP; Daniel E. Singer, MD; Albert L. Waldo, MD, FACC, FAHA, FHRS, FAACP
Atrial Fibrillation Patient Survey—Highlights
This survey of more than 500 atrial fibrillation patients, ages 65+ from across the nation, revelead diagnosis and treatment experiences, information on anticoagulant use, stroke and bleeding risk discussions with health care professionals, and more. It was conducted as part of the AFib Optimal Treatment Task Force.
You can also read the FULL RESULTS.
Atrial Fibrillation Health Care Professional Survey—Highlights
A survey of more than 400 geriatricians, internists, and primary care physicians revealed a number of barriers to optimal AFib anticoagulation including confusion when it comes to guidelines and tools, overemphasis of individual factors like frailty and risk of falls, and more.
You can also read the FULL RESULTS.
How Older Adults Are Benefiting from the Internet of Things
Author: Julie Potyraj
Date: August 19th, 2016
With continued advances in health information technology and other factors, there is more data being collected about our health and behaviors than ever before. One of the major enablers of this dynamic is the explosion of the Internet of Things (IoT)—a phenomenon that offers a growing array of benefits. Here, we’ll take a closer look at the Internet of Things—including how older adults are both contributing to and benefiting from these increasingly common technologies.
Alliance President and CEO Sue Peschin Featured on Agewyz Podcast
Author: Breanna Bishop
Date: August 4th, 2016
Alliance CEO and President Sue Peschin spoke with Agewyz's Jana Panarites about the elders in her family who continue to inspire her and how the Alliance is working to advocate for older Americans and their caregivers.
Superbugs and Seniors
Author: Cynthia Bens
Date: September 26th, 2014
The Alliance for Aging Research was fortunate enough to host an amazing group of leaders from the fields of aging, infectious disease, health care and government to discuss the disproportionate impact of healthcare-associated infections (HAI) on older adults.
CER for More Patient-Centered Care
Author: Cynthia Bens
Date: May 23rd, 2014
There is increasing emphasis on shaping a system that makes optimal patient outcomes a priority. The Alliance has been paying close attention to Patient-Centered Outcomes Research Institute’s (PCORI) initial work to provide information on which treatments and technologies deliver the best results.
Challenges and Opportunities for PCORI and CER
Author: Guest Contributor
Date: January 30th, 2012
In a time of skyrocketing health care costs, both the private and public sectors struggle to balance economics with access to high quality health care. Evidence from comparative effectiveness research (CER) and “head-to-head” clinical trials is increasingly being used in health care treatment decision-making around the globe, but how will this affect access to quality care? More importantly, where will the public draw the line between cost and access?
Save the SHIP
In this edition of Get Mad before You Get Old, learn about the importance of the Medicare State Health Insurance Program (SHIP), which provides in-person and over-the-phone Medicare counseling to seniors and people with disabilities.
Turning the Lights on Superbugs
Date: November 24th, 2014
VP of Public Policy Cynthia Bens gets "mad" and talks about the seriousness of healthcare-associated infections.
Sepsis: Common & Deadly
Every year as many as one million Americans develop sepsis—a life-threatening medical condition that arises when the body initiates a powerful immune response against an infection. All types of infection can lead to sepsis—from an infected scrape, to pneumonia, to an infection at a surgical incision site, and no matter what the origin, sepsis can lead to death.
Alzheimer's Treatment and Care at a Crossroads: Pursuing All Avenues to Provide Relief
If you or a loved one has been diagnosed with Alzheimer’s disease, you’ve most likely wondered if there are any ways to relieve some of the burden of the disease, in addition to the pills to manage its symptoms. For many diseases like heart disease and diabetes, changes to diet and exercise are as high on health care providers list of advice for patients as a prescription for medication, but this isn’t the case with how they approach Alzheimer’s disease.